CORE--TECHNOLOGIES FOR RECOMBINANT PROTEINS AND ASSAY REAGENTS

Information

  • Research Project
  • 6103097
  • ApplicationId
    6103097
  • Core Project Number
    U19CA067861
  • Full Project Number
    7U19CA067861-03
  • Serial Number
    67861
  • FOA Number
  • Sub Project Id
    9001
  • Project Start Date
    9/30/1997 - 27 years ago
  • Project End Date
    8/31/1998 - 26 years ago
  • Program Officer Name
  • Budget Start Date
    -
  • Budget End Date
    -
  • Fiscal Year
    1997
  • Support Year
    3
  • Suffix
  • Award Notice Date
    -
Organizations

CORE--TECHNOLOGIES FOR RECOMBINANT PROTEINS AND ASSAY REAGENTS

The Molecular Biology Core Facility is responsible for supplying all reagents necessary to each of the ELISA-based screens, protein crystallization and structure-activity studies of lead compounds directed toward the biochemical mechanism of action of lead candidates. These reagents include recombinant purified proteins, oligonucleotides, and monoclonal/polyclonal antibodies. The core facility has established the necessary technology and the expertise to efficiently supply these reagents.

IC Name
NATIONAL CANCER INSTITUTE
  • Activity
    U19
  • Administering IC
    CA
  • Application Type
    7
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
  • Study Section Name
  • Organization Name
    GENZYME CORPORATION
  • Organization Department
  • Organization DUNS
  • Organization City
    FRAMINGTON
  • Organization State
    MA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    017028803
  • Organization District
    UNITED STATES